Donepezil HCl
| 제품명 | Donepezil HCl |
|---|---|
| CAS 번호 | 120011-70-3 |
| 동의어 | Donepezil hydrochloride, E2020, Aricept, (±)-2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride |
| 분자식 | C24H29NO3·HCl |
| 분자량 | 415.95 g/mol |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | 98.0% – 102.0% (on dried basis) |
| 용해도 | Soluble in water, methanol, and chloroform; slightly soluble in ethanol |
| 건조 손실 | ≤ 0.5% |
| 소각 잔류물 | ≤ 0.1% |
| 중금속 | 10 ppm 이하 |
| 패키지 | 25 kg fiber drum with double polyethylene bags |
도움이 필요하신가요? 저희 팀에 문의해 주세요

동의어: Donepezil hydrochloride, E2020, Aricept, (±)-2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride
Donepezil HCl has become a staple in the portfolios of generic drug manufacturers and CDMOs targeting the central nervous system (CNS) segment. With the global rise in Alzheimer’s disease prevalence and the ongoing shift toward affordable generics, demand for this API remains robust across regulated and emerging markets alike.
Chemically, Donepezil HCl is a piperidine-based indanone derivative. It is the hydrochloride salt of donepezil, a reversible acetylcholinesterase inhibitor. The free base is a viscous oil, but the hydrochloride form offers the crystallinity and water solubility required for solid oral dosage forms.
LyvBio supplies Donepezil HCl in a single, high-purity grade suitable for immediate formulation into film-coated tablets. Our material is manufactured under cGMP conditions, with full traceability and regulatory support.
Donepezil HCl is a synthetic small molecule with a molecular weight of 415.95 g/mol. It is a white to off-white crystalline powder, freely soluble in water and methanol. The molecule contains a dimethoxyindanone moiety linked via a methylene bridge to a benzylpiperidine ring, a structure that confers high selectivity for acetylcholinesterase over butyrylcholinesterase.
Our production process yields a single polymorphic form, ensuring consistent dissolution and bioavailability across batches. Each lot is tested for assay, related substances, residual solvents, and particle size to meet the tight specifications of solid dosage manufacturing.
| 매개변수 | 사양 |
|---|---|
| 분석법 (HPLC) | 98.0% – 102.0% |
| 건조 손실 | ≤ 0.5% |
| 중금속 | 10 ppm 이하 |
| 소각 잔류물 | ≤ 0.1% |
| Microbial Limits | Total aerobic count ≤ 1000 CFU/g; Yeast & Mold ≤ 100 CFU/g; E. coli absent |
| 입자 크기 | D90 ≤ 50 µm (customizable) |